{"DataElement":{"publicId":"2768637","version":"2","preferredName":"Hematopoietic Cell Transplantation Relationship Death Main Reason Type","preferredDefinition":"An explanation that describes the hematopoietic cell transplantation related main cause(s) of death.","longName":"2768630v2.0:2768632v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2768630","version":"2","preferredName":"Hematopoietic Cell Transplantation Relationship Death Main Reason","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._A state of connectedness between people, objects, or events; to be associated or connected with something._The absence of life or state of being dead._Most important; principal._An explanation of the cause of some phenomenon or action.","longName":"2768628v1.0:2768363v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2768628","version":"1","preferredName":"Hematopoietic Stem Cell Transplantation Relationship Death","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):The grafting of tissues from one individual to another or place to place within a single individual.:Related; connected or associated.:The absence of life or state of being dead.","longName":"C12551:C15342:C25648:C28554","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52DBB408-04A3-67E2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-25","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-07-25","modifiedBy":"ONEDATA","dateModified":"2008-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2768363","version":"1","preferredName":"Main Reason","preferredDefinition":"Most important; principal.:An explanation of the cause of some phenomenon or action.","longName":"C25562:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Main","conceptCode":"C25562","definition":"Most important; principal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52B76BB1-FC96-4467-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-23","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-07-23","modifiedBy":"ONEDATA","dateModified":"2008-07-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E50FB33-2AAC-90D5-E050-BB89AD4329A2","latestVersionIndicator":"Yes","beginDate":"2015-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"KUMMEROA","dateModified":"2021-02-23","changeDescription":". 2021-2-23 ak Ok to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2768632","version":"2","preferredName":"Hematopoietic Cell Transplantation Relationship Reason Death Type","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._A state of connectedness between people, objects, or events; to be associated or connected with something._An explanation of the cause of some phenomenon or action._The absence of life or state of being dead._Type; a subdivision of a particular kind of thing.","longName":"2768632v2.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"31","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"GVHD","valueDescription":"Graft Versus Host Disease","ValueMeaning":{"publicId":"2636869","version":"1","preferredName":"Graft Versus Host Disease","longName":"2636869","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FF979BE-A605-6817-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-05-08","modifiedBy":"GDEEN","dateModified":"2023-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E50FB33-2A4A-90D5-E050-BB89AD4329A2","beginDate":"2008-07-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"},{"value":"Cardiac toxicity","valueDescription":"Cardiotoxicity","ValueMeaning":{"publicId":"2571817","version":"1","preferredName":"Cardiotoxicity","longName":"2571817","preferredDefinition":"Toxicity that impairs or damages the heart. This condition is often caused by the administration of a pharmaceutical agent that initiates a poisonous or toxic response in cardiac tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiotoxicity","conceptCode":"C27994","definition":"Toxicity that impairs or damages the heart. This condition is often caused by the administration of a pharmaceutical agent that initiates a poisonous or toxic response in cardiac tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E596-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-08","modifiedBy":"CZECHS","dateModified":"2008-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E50FB33-2A54-90D5-E050-BB89AD4329A2","beginDate":"2008-07-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection and infestation","ValueMeaning":{"publicId":"2751403","version":"1","preferredName":"Infection and infestation","longName":"2751403","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0AF1-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E50FB33-2A5E-90D5-E050-BB89AD4329A2","beginDate":"2008-07-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"},{"value":"Pulmonary toxicity","valueDescription":"Toxicity Pulmonary","ValueMeaning":{"publicId":"2768633","version":"1","preferredName":"Toxicity Pulmonary","longName":"2768633","preferredDefinition":"Toxicity; the degree to which something is poisonous.: Relating to the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52DDF902-A2BA-5647-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-07-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E50FB33-2A68-90D5-E050-BB89AD4329A2","beginDate":"2008-07-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E50FB33-2A72-90D5-E050-BB89AD4329A2","beginDate":"2008-07-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"},{"value":"Rejection / poor graft function","valueDescription":"Graft Rejection","ValueMeaning":{"publicId":"2779293","version":"1","preferredName":"Graft Rejection","longName":"2779293","preferredDefinition":"Failure of transplanted tissue to become functional or operational, often as a result of destruction by the host's immune system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Failure","conceptCode":"C75570","definition":"Failure of transplanted tissue to become functional or operational, often as a result of destruction by the host's immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55EE40E7-CD96-5FD7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-09-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E50FB33-2A7C-90D5-E050-BB89AD4329A2","beginDate":"2008-09-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"},{"value":"VOD","valueDescription":"Hepatic Veno-Occlusive Disease","ValueMeaning":{"publicId":"2793925","version":"1","preferredName":"Hepatic Veno-Occlusive Disease","longName":"2793925","preferredDefinition":"Blockage of the small- or medium-sized hepatic veins due to nonthrombotic subendothelial edema which may progress to fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinusoidal Obstruction Syndrome","conceptCode":"C26793","definition":"A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"594FA4A3-3296-6DA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-10-15","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E50FB33-2A86-90D5-E050-BB89AD4329A2","beginDate":"2008-07-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E51253F-5187-36C4-E050-BB89AD434054","beginDate":"2015-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"},{"value":"New malignancy","valueDescription":"New Malignant Neoplasm","ValueMeaning":{"publicId":"4732513","version":"1","preferredName":"New Malignant Neoplasm","longName":"4732513","preferredDefinition":"Having no previous example or precedent or parallel; of a kind not seen before.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10694E6B-6DAC-79A6-E050-BB89AD433E9A","latestVersionIndicator":"Yes","beginDate":"2015-03-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E51253F-5191-36C4-E050-BB89AD434054","beginDate":"2015-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"},{"value":"Relapse / progression / persistent disease","valueDescription":"Recurrent Disease Progressive Disease Or Persistent Disease","ValueMeaning":{"publicId":"4987292","version":"1","preferredName":"Recurrent Disease Progressive Disease Or Persistent Disease","longName":"4987292","preferredDefinition":"The return of a disease after a period of remission.: Cancer that is increasing in scope or severity.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A disease that does not go to remission despite treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Persistent Disease","conceptCode":"C90169","definition":"A disease that does not go to remission despite treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E51253F-51AE-36C4-E050-BB89AD434054","latestVersionIndicator":"Yes","beginDate":"2015-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E51253F-51C7-36C4-E050-BB89AD434054","beginDate":"2015-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"ONEDATA","dateModified":"2015-08-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2779788","version":"1","preferredName":"Hematopoietic Stem Cell Transplantation Relationship Reason Death Type","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):The grafting of tissues from one individual to another or place to place within a single individual.:Related; connected or associated.:An explanation of the cause of some phenomenon or action.:The absence of life or state of being dead.:Type; a subdivision of a particular kind of thing.","longName":"C12551:C15342:C25648:C25638:C2","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55F15C0C-0112-46DE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-02","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-09-02","modifiedBy":"ONEDATA","dateModified":"2008-09-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E50FB33-2A32-90D5-E050-BB89AD4329A2","latestVersionIndicator":"Yes","beginDate":"2015-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"KUMMEROA","dateModified":"2021-02-23","changeDescription":".-2021-2-23 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964925","version":"1","longName":"2450r1: Post-TED","context":"NHLBI"},{"publicId":"3160397","version":"1","longName":"2455: Selective Post-Transplant Essential Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedClinicalInterpretation:value","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"HSCT related causes","type":"Alternate Question Text","description":"HSCT related causes","url":null,"context":"NHLBI"},{"name":"What are the HCT related main","type":"Preferred Question Text","description":"What are the HCT related main cause(s) of death?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2768637","type":"BRIDG Mapping Path","description":"PerformedMedicalConditionResult [death] > AssessedResultRelationship > PerformedObservation [primary etiology] > PerformedClinicalInterpretation.value(ANY=>DSET<CD>).item(CD).code WHERE  PerformedMedicalConditionResult.value = \"death\" AND AssessedResultRelationship.typeCode = \"primary etiology\" AND PerformedSubstanceAdministration.dateRange [transplant] IS LESS THAN PerformedObservation.dateRange [post-HSCT condition identifcation] AND PerformedObservation.dateRange [post-HSCT condition identifcation] IS LESS THAN PerformedMedicalConditionResult.occurrenceDateRange [death] AND PerformedObservation.dateRange [post-HSCT condition identifcation] > PerformedObservationResult [post-HSCT condition] AND PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"Administer Hematopoietic Stem Cell Product{transplantation}\"","url":null,"context":"NHLBI"},{"name":"Primary cause of death","type":"Application Standard Question Text","description":"Primary cause of death","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E51253F-4F51-36C4-E050-BB89AD434054","latestVersionIndicator":"Yes","beginDate":"2008-07-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-08-27","modifiedBy":"KUMMEROA","dateModified":"2021-02-23","changeDescription":". 2021-2-23 ak OK to release per WZ. System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}